HELX - Franklin Genomic Advancements ETF
|Ex-Dividend Date||Dec 14, 2020|
|Trading Day||April 16|
|Day's Range||45.04 - 45.89|
|52-Week Range||25.09 - 53.47|
The investment seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
|Asset Class |
|Inception Date |
Feb 25, 2020
|Ticker Symbol |
|Index Tracked |
Solactive Genomics Index
Top 10 Holdings42.72% of assets
|WUXI BIOLOGICS CAYMAN INC||2269.HK||5.81%|
|Dec 14, 2020||$0.00501||Jan 1, 1970|
There are no news available yet.